1. Rosiglitazone sales suspended in Europe, restricted in US

   News item 14 January 2013 Pages: 1 - 1

2. Octagam recalled from market

   News item 14 January 2013 Pages: 2 - 2

3. The US FDA has issued new recommendations regarding the dosing of valganciclovir [Valcyte] in paediatric patients.

   News item 14 January 2013 Pages: 2 - 2

4. A new UK system being piloted will enable the capture of ADR data and a Yellow Card to be produced

   News item 14 January 2013 Pages: 2 - 2

5. The European Medicines Agency's CHMP confirms the positive benefit-risk balance of the rotavirus vaccine Rotateq.

   News item 14 January 2013 Pages: 2 - 2

6. Safety update for influenza vaccines in Europe and Australia

   News item 14 January 2013 Pages: 3 - 3

7. Several products marketed as dietary supplements have been recalled by the US FDA

   News item 14 January 2013 Pages: 3 - 3

8. A voluntary, precautionary recall of certain lots of Epogen and Procrit (epoetin-α) vials is being enacted

   Media release 14 January 2013 Pages: 3 - 3

9. News from ICPE

   Meeting report 14 January 2013 Pages: 4 - 5

10. Antipsychotics associated with elevated VTE risk

    News item 14 January 2013 Pages: 6 - 6

11. Adverse events do not affect compliance with HIV PEP

    Clinical study 14 January 2013 Pages: 6 - 6

12. Iodixanol linked to fewer adverse events than iopamidol

    Clinical study 14 January 2013 Pages: 6 - 6

13. Amoxicillin

    Case report 14 January 2013 Pages: 7 - 7

14. Amitriptyline/tianeptine overdose

    Case report 14 January 2013 Pages: 7 - 7

15. Antiparkinsonians

    Case report 14 January 2013 Pages: 7 - 8

16. Artemether/lumefantrine

    Case report 14 January 2013 Pages: 8 - 8

17. Antiparkinsonians

    Case report 14 January 2013 Pages: 8 - 8

18. Asparaginase

    Case report 14 January 2013 Pages: 8 - 8

19. Azathioprine/budesonide/methylprednisolone

    Case report 14 January 2013 Pages: 9 - 9

20. Azithromycin

    Case report 14 January 2013 Pages: 9 - 9

21. Aspirin/clopidogrel

    Case report 14 January 2013 Pages: 9 - 9

22. Atorvastatin/tacrolimus interaction

    Case report 14 January 2013 Pages: 9 - 9

23. Bevacizumab

    Case report 14 January 2013 Pages: 10 - 10

24. BCG

    Case report 14 January 2013 Pages: 10 - 10

25. Bisphosphonates

    Case report 14 January 2013 Pages: 10 - 10

26. Bevacizumab

    Case report 14 January 2013 Pages: 10 - 10

27. Bromazepam

    Case report 14 January 2013 Pages: 11 - 11

28. Bupivacaine

    Case report 14 January 2013 Pages: 11 - 11

29. Buprenorphine abuse

    Case report 14 January 2013 Pages: 11 - 12

30. Capecitabine

    Case report 14 January 2013 Pages: 12 - 12

31. Cabergoline

    Case report 14 January 2013 Pages: 12 - 12

32. Calcitriol

    Case report 14 January 2013 Pages: 12 - 12

33. Ciclosporin/simvastatin interaction

    Case report 14 January 2013 Pages: 13 - 13

34. Carboplatin

    Case report 14 January 2013 Pages: 13 - 13

35. Carbamazepine

    Case report 14 January 2013 Pages: 13 - 13

36. Ciclosporin

    Case report 14 January 2013 Pages: 13 - 13

37. Clarithromycin

    Case report 14 January 2013 Pages: 14 - 14

38. Cocaine/hydrocodone/paracetamol

    Case report 14 January 2013 Pages: 14 - 14

39. Clindamycin/tacrolimus interaction

    Case report 14 January 2013 Pages: 14 - 14

40. Conjugated estrogens/cyproterone

    Case report 14 January 2013 Pages: 15 - 15

41. Conjugated estrogens

    Case report 14 January 2013 Pages: 15 - 15

42. Cytarabine/fludarabine

    Case report 14 January 2013 Pages: 15 - 15

43. Corticosteroids

    Case report 14 January 2013 Pages: 15 - 15

44. Efalizumab

    Case report 14 January 2013 Pages: 16 - 16

45. Enoxaparin sodium

    Case report 14 January 2013 Pages: 16 - 16

46. Dextropropoxyphene/tramadol

    Case report 14 January 2013 Pages: 16 - 16

47. Doxorubicin

    Case report 14 January 2013 Pages: 16 - 16

48. Doxorubicin/idarubicin

    Case report 14 January 2013 Pages: 16 - 16

49. Epinephrine

    Case report 14 January 2013 Pages: 17 - 17

50. Etoposide

    Case report 14 January 2013 Pages: 17 - 17